Education
About Us
Working with TipRanks
Follow Us
Biomind Labs Inc (TSE:BMND)
:BMND
Bmnd08, Brain Electrical Activity Monitor, Pharmacokinetic Study Of Sublingually Administered Psychoactive Substance, Biochemical Determinations, Acute Subjective Ratings Of Psychedelic Effects, Vital Signs, Cognitive Assessments, Psychiatric Assessments
Healthy Volunteers
Phase I/II
Completed
Safety, Tolerability, and Efficacy of Sublingual Microdoses of 5-MeO-DMT for Depression and Anxiety
Dec 10, 2024
―
Acute Subjective Ratings Of Psychedelic Effects, Vital Signs, Cognitive Assessments, Psychiatric Assessments, Sublingual Administration, Electroencephalography, Biochemical Mesurements
Mild Cognitive Impairment, Anxiety State, Depression Anxiety Disorder
Phase I/II
Completed
Efficacy of Sublingual 5-MeO-DMT for Reducing Anxiety and Depression in MCI
Dec 10, 2024
―
N,N-Dimethyltryptamine
Healthy Volunteers
Phase I
Completed
Clinical Study of DMT in Healthy Adults
Oct 06, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Biomind Labs Inc (BMND) have in its pipeline
BMND is currently developing the following drugs: Bmnd08, Brain Electrical Activity Monitor, Pharmacokinetic Study Of Sublingually Administered Psychoactive Substance, Biochemical Determinations, Acute Subjective Ratings Of Psychedelic Effects, Vital Signs, Cognitive Assessments, Psychiatric Assessments, Acute Subjective Ratings Of Psychedelic Effects, Vital Signs, Cognitive Assessments, Psychiatric Assessments, Sublingual Administration, Electroencephalography, Biochemical Mesurements, N,N-Dimethyltryptamine. These drug candidates are in various stages of clinical development as the company works toward FDA approval.